Topic: presidential election
President Donald Trump has a history of slamming drugmakers, but this week's insult could save the industry some money.
Biopharma shares soared with Donald Trump's presidential victory as the threat of sweeping action against drug prices lifted. But Trump won't be idle on pricing, analysts say, and his ferocious opposition to trade deals could be a long-term headache for the decidedly global pharma business.
When a single tweet from Hillary Clinton sent biopharma shares tumbling last fall, her campaign staff gleefully declared war on pharma, according to newly released WikiLeaks emails.